Irvine Pharmaceutical Services

irvinepharma.com

Since Irvine Pharmaceutical Services was first established in 1988, Irvine has earned its reputation for outstanding analytical testing from small molecules to biologics.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET, PHARMA TECH

SHIELDS HEALTH SOLUTIONS AND ELLIOT HEALTH SYSTEM ESTABLISH NEW SPECIALTY PHARMACY SERVICES

Businesswire | April 12, 2023

news image

Shields Health Solutions the premier specialty pharmacy accelerator in the country, announces that it is partnering with Elliot Health System, the largest provider of comprehensive healthcare services in Southern New Hampshire, to launch a new pharmacy program to meet the unique needs of patients with complex, chronic conditions. The program will increase access to specialized pharmacy services designed to lower costs, expand treatment options, enhance medication management, and improve ov...

Read More

GLOBAL ASEPTIC PACKAGING FOR THE PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE OUTLOOK TO 2025

Fashion Trends Now | April 09, 2020

news image

The research report on “Global Aseptic Packaging for the Pharmaceutical Market” serves in-depth analysis on latest and upcoming market scenario of Aseptic Packaging for the Pharmaceutical in the appraisal period, 2020-2025. The report survey Aseptic Packaging for the Pharmaceutical market growth past, sales channel, players profiled in Aseptic Packaging for the Pharmaceutical industry, product type and application market share and Aseptic Packaging for the Pharmaceutical regional sco...

Read More

Research, PHARMA TECH

IONIS PHARMA'S EPLONTERSEN FOR ATTRV-PN GETS FDA'S NDA ACCEPTANCE

Ionis Pharmaceuticals, Inc. | March 10, 2023

news image

Ionis Pharmaceuticals, a leading RNA-targeted therapy firm, recently announced that the USFDA has accepted for review a new drug application (NDA) for eplontersen. Eplontersen is an investigational antisense medicine designed to reduce the production of transthyretin (TTR) protein and treat hereditary and non-hereditary forms of ATTR amyloidosis (ATTR). The NDA has been given a Prescription Drug User Fee Act (PDUFA) action date of December 22, 2023. The FDA has declared that no ...

Read More

VIEWS AND ANALYSIS, PHARMACY MARKET

SOLIGENIX INITIATES PHASE 2 CLINICAL TRIAL OF SGX302 (SYNTHETIC HYPERICIN) FOR THE TREATMENT OF MILD-TO-MODERATE PSORIASIS

Soligenix, Inc. | December 20, 2022

news image

Soligenix, Inc. a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that patient enrollment has been opened for its Phase 2a study evaluating SGX302 in the treatment of mild-to-moderate psoriasis. Psoriasis is an ongoing unmet medical need, with as many as 7.5 million people in the U.S. and 60-125 million people worldwide affected by this incurable disease. ...

Read More
news image

PHARMACY MARKET, PHARMA TECH

SHIELDS HEALTH SOLUTIONS AND ELLIOT HEALTH SYSTEM ESTABLISH NEW SPECIALTY PHARMACY SERVICES

Businesswire | April 12, 2023

Shields Health Solutions the premier specialty pharmacy accelerator in the country, announces that it is partnering with Elliot Health System, the largest provider of comprehensive healthcare services in Southern New Hampshire, to launch a new pharmacy program to meet the unique needs of patients with complex, chronic conditions. The program will increase access to specialized pharmacy services designed to lower costs, expand treatment options, enhance medication management, and improve ov...

Read More
news image

GLOBAL ASEPTIC PACKAGING FOR THE PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE OUTLOOK TO 2025

Fashion Trends Now | April 09, 2020

The research report on “Global Aseptic Packaging for the Pharmaceutical Market” serves in-depth analysis on latest and upcoming market scenario of Aseptic Packaging for the Pharmaceutical in the appraisal period, 2020-2025. The report survey Aseptic Packaging for the Pharmaceutical market growth past, sales channel, players profiled in Aseptic Packaging for the Pharmaceutical industry, product type and application market share and Aseptic Packaging for the Pharmaceutical regional sco...

Read More
news image

Research, PHARMA TECH

IONIS PHARMA'S EPLONTERSEN FOR ATTRV-PN GETS FDA'S NDA ACCEPTANCE

Ionis Pharmaceuticals, Inc. | March 10, 2023

Ionis Pharmaceuticals, a leading RNA-targeted therapy firm, recently announced that the USFDA has accepted for review a new drug application (NDA) for eplontersen. Eplontersen is an investigational antisense medicine designed to reduce the production of transthyretin (TTR) protein and treat hereditary and non-hereditary forms of ATTR amyloidosis (ATTR). The NDA has been given a Prescription Drug User Fee Act (PDUFA) action date of December 22, 2023. The FDA has declared that no ...

Read More
news image

VIEWS AND ANALYSIS, PHARMACY MARKET

SOLIGENIX INITIATES PHASE 2 CLINICAL TRIAL OF SGX302 (SYNTHETIC HYPERICIN) FOR THE TREATMENT OF MILD-TO-MODERATE PSORIASIS

Soligenix, Inc. | December 20, 2022

Soligenix, Inc. a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that patient enrollment has been opened for its Phase 2a study evaluating SGX302 in the treatment of mild-to-moderate psoriasis. Psoriasis is an ongoing unmet medical need, with as many as 7.5 million people in the U.S. and 60-125 million people worldwide affected by this incurable disease. ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us